Minnesota RETAIN Phase 2 (Sub-study)

Disability Clinical Trial

— MN RETAIN  

Official title:

Minnesota Retaining Employment and Talent After Injury/Illness Network Phase 2 RETAIN

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT05216016
• Other study ID #: 21-006979
• Secondary ID: FP00100838.02
• Status: Active, not recruiting
• Phase: N/A
• Start date: December 23, 2021
• Est. completion date: May 2026

Study information

• Verified date: June 2024
• Source: Mayo Clinic
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

MN RETAIN Phase 2 Sub-study is a non-randomized trial to evaluate the impact of RETAIN program expansion and services on workforce retention and reduction of future workplace disability in the state of MN. The program is funded by US Department of Labor (US DOL) and sponsored jointly with the US Social Security Administration. There will be collaboration between partners to implement best practices in early intervention to support injured or ill employees in stay-at-work and return-to-work. MN RETAIN involves a partnership between Mayo Clinic and MN Department of Employment and Economic Development (DEED), MN Department of Labor and Industry (DLI), MN Department of Health (MDH), Workforce Development, Inc. (WDI), and the Governor's Workforce Development Board. MN DEED serves as the main recipient and administrator of the funding within the state with Mayo Clinic, DLI, and WDI, as subrecipients of the grant.

(Effective Date: 12/23/2021-05/16/2024) MN RETAIN Phase 2 : This study is a randomized control trial (RCT) to evaluate the impact of RETAIN program expansion and services on workforce retention and reduction of future workplace disability in the state of MN. The program is funded by US Department of Labor (US DOL) and sponsored jointly with the US Social Security Administration. There will be collaboration between partners to implement best practices in early intervention to support injured or ill employees in stay-at-work and return-to-work. MN RETAIN involves a partnership between Mayo Clinic and MN Department of Employment and Economic Development (DEED), MN Department of Labor and Industry (DLI), MN Department of Health (MDH), Workforce Development, Inc. (WDI), and the Governor's Workforce Development Board. MN DEED serves as the main recipient and administrator of the funding within the state with Mayo Clinic, DLI, and WDI, as subrecipients of the grant. During this Phase: additional collaborators: Mathematica Policy Research

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 5200
• Est. completion date: May 2026
• Est. primary completion date: May 2025
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria

• > 18-years-old

• MN Resident

• Works in MN

• Employed at the time of enrollment

• Within 6 months of last day of work

• Meets one of the following:

• Provider work restrictions of unable to work for at least 4 weeks

• Per healthcare team anticipated to be unable to work for at least 4 weeks

• Employer's inability to accommodate current work restrictions

• Meets one of the following:

• Diagnosis of a work related or personal injury or illness that impacts employment

• Invasive procedure (e.g., surgery) anticipated within the next 4-weeks that impacts employment

• Documentation of work restrictions (i.e., written note/form documentation in electronic medical record prior to enrollment)

Exclusion Criteria

• Legal representation/litigation at the time of enrollment related to a workers' compensation medical condition

• Does not have the capacity to give appropriate informed consent

• Employed by a RETAIN healthcare recipient or subrecipient with an existing return to work program for employees (i.e., Mayo Clinic employees)

• Workers' compensation recipients that have a qualified rehabilitation consultant (QRC) or a disability case manager (DCM)

• Pending application OR Receiving Social Security Disability Insurance (SSDI) or Supplemental Security Income (SSI)

• Self-Employed

Related Conditions & MeSH terms

• Disability
• Wounds and Injuries

Intervention

Other:
• RETAIN Program
Facilitates early intervention strategies to support workers in staying-at or returning-to-work (SAW/RTW) after injury or illness and preventing unnecessary disability. This is done by incorporating a Return-to-Work Case Manager as a member of the healthcare clinical team who acts as a liaison for the patient and assists in coordination of referrals between healthcare and Workforce Development services. Return-to-Work Case Managers will interact with treating providers of Minnesota RETAIN intervention group participants to ensure functionally based work restrictions are documented and shared with the patient's employer.

Locations

Country	Name	City	State
United States	Mayo Clinic Rochester	Rochester	Minnesota

Sponsors (7)

Lead Sponsor	Collaborator
Mayo Clinic	Minnesota Department of Employment and Economic Development, Minnesota Department of Health, Minnesota Department of Labor and Industry, United States Department of Labor, United States Social Security Administration, Workforce Development, Inc.

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Workers to maintain employment	Total number of workers employed at the time of program completion and who have maintained employment 12 months after enrollment.	12 months
Primary	Reduction on work disability at 1 years	Total number of enrollees that applied for SSDI or SSI during any of the 1 year after enrollment.	1 year
Primary	Reduction in long term work disability	Total number of enrollees that applied for SSDI or SSI during any of the 5 year after enrollment.	5 years